6 research outputs found

    Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies

    No full text
    Amplification of epidermal growth factor receptor (EGFR) and its active mutant EGFRvIII occurs frequently in glioblastoma (GBM). While EGFR and EGFRvIII play critical roles in pathogenesis, targeted therapy with EGFR-tyrosine kinase inhibitors (TKIs) or antibodies has only shown limited efficacy in patients. Here we discuss signaling pathways mediated by EGFR/EGFRvIII, current therapeutics, and novel strategies to target EGFR/EGFRvIII-amplified GBM

    Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers

    No full text

    The evolution of tumour phylogenetics: principles and practice

    No full text
    corecore